DEA Delays Production Of Marijuana Drug As Potential Treatment For MS And Huntington’s Disease
By Nina Zdinjak MMJ International Holdings, in collaboration with a specialty pharmaceutical options company, has been production gelatin capsule medications dependent on compounds discovered in cannabis. The company will investigate these in clinical trials as likely treatment options for many sclerosis (MS) and Huntington’s disease (Hd). The Providens, Rhode Island-dependent health care hashish investigate company had entered into a offer agreement […]